Peter Attia· MD
or or you can do it not in the germ line but but just in the somatic cells yeah um and that that could also be beneficial
Loading…
The headline is broadly defensible, but the qualifications matter. Effect sizes vary by population, the strongest claims rest on shorter trials, and credible voices push back on how it's typically framed.
or or you can do it not in the germ line but but just in the somatic cells yeah um and that that could also be beneficial
Every Sunday: the week’s new conflicts and verdict changes — and nothing else.
Native comments, Twitter mentions, and Reddit threads about this claim — surfaced together so the conversation isn't fragmented across platforms.
Bookmarking — the dossier-vs-overview split is the right call. Most of the time I want overview; sometimes I want receipts.
Would love a "what would change this verdict" RSS feed. Sign me up if it exists.
The other way is we'll have more and more gene therapies that are somatic, not germline, but they're done at early age maybe to cure, you know, early onset childhood diseases or maybe even done in fetuses but not in germline. So people will say, "Oh, yeah, you can do it really, really early in utero. What are we really worried about?" And some of these gene therapies as people start to get...to be quite old will say, "Okay, it doesn't have long-term consequences."